Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2006 1
2007 4
2008 1
2009 1
2010 1
2015 1
2016 2
2019 1
2021 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Long-term results of PRRT in advanced bronchopulmonary carcinoid.
Mariniello A, Bodei L, Tinelli C, Baio SM, Gilardi L, Colandrea M, Papi S, Valmadre G, Fazio N, Galetta D, Paganelli G, Grana CM. Mariniello A, et al. Among authors: papi s. Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):441-52. doi: 10.1007/s00259-015-3190-7. Epub 2015 Sep 21. Eur J Nucl Med Mol Imaging. 2016. PMID: 26392198
First Ex Vivo Results of β--Radioguided Surgery in Small Intestine Neuroendocrine Tumors with 90Y-DOTATOC.
Bertani E, Collamati F, Colandrea M, Faccini R, Fazio N, Ferrari ME, Fischetti M, Fumagalli Romario U, Funicelli L, De Simoni M, Mancini-Terracciano C, Mirabelli R, Morganti S, Papi S, Pisa E, Solfaroli-Camillocci E, Spada F, Cremonesi M, Grana CM. Bertani E, et al. Among authors: papi s. Cancer Biother Radiopharm. 2021 Jun;36(5):397-406. doi: 10.1089/cbr.2020.4487. Epub 2021 Feb 18. Cancer Biother Radiopharm. 2021. PMID: 33601932
Peptide receptor radionuclide therapy with 177Lu- or 90Y-SSTR peptides in malignant pheochromocytomas (PCCs) and paragangliomas (PGLs): results from a single institutional retrospective analysis.
Rubino M, Di Stasio GD, Bodei L, Papi S, Rocca PA, Ferrari ME, Fodor CI, Bagnardi V, Frassoni S, Mei R, Fazio N, Ceci F, Grana CM. Rubino M, et al. Among authors: papi s. Endocrine. 2024 Feb 7. doi: 10.1007/s12020-024-03707-5. Online ahead of print. Endocrine. 2024. PMID: 38324106
High activity 90Y-ibritumomab tiuxetan (Zevalin) with peripheral blood progenitor cells support in patients with refractory/resistant B-cell non-Hodgkin lymphomas.
Ferrucci PF, Vanazzi A, Grana CM, Cremonesi M, Bartolomei M, Chinol M, Ferrari M, Radice D, Papi S, Martinelli G, Paganelli G. Ferrucci PF, et al. Among authors: papi s. Br J Haematol. 2007 Nov;139(4):590-9. doi: 10.1111/j.1365-2141.2007.06869.x. Br J Haematol. 2007. PMID: 17979944 Free article.
13 results